| Literature DB >> 19427443 |
Xiaoliang Qiu1, Wenling Liu, Dayi Hu, Tiangang Zhu, Cuilan Li, Lei Li, Chengjun Guo, Xingpeng Liu, Lei Wang, Hua Zheng, Chunling Wang, Qing Diao, Dan Shi, Pingyun Zhan, Yuanming Deng, Kunshen Liu, Yi Wang, Baomin Liu, Hongming Liu, Li Zhang.
Abstract
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited heart muscle disease associated with increased risks of sudden death, particularly in young, otherwise healthy, patients. The pathologic features are progressive myocardial atrophy and fibrofatty replacement. Plakophilin-2 (PKP2) is reported as the most common ARVD/C-causing gene in Western countries. In this study we aimed to determine the prevalence of PKP2 mutations in Chinese patients with ARVD/C and their phenotype characteristics. Genotype and phenotype were investigated in a cohort of 18 unrelated Chinese patients with a clinical diagnosis of ARVD/C. Direct sequencing of PKP2 led to the identification of 5 novel heterozygous mutations (R158K, Q211X, L419S, A793D, and N852fsX930) in 39% of patients (7 of 18) with ARVD/C. Among them, N852fsX930 was found in 3 unrelated young patients who presented with symptomatic ventricular tachyarrhythmia. Nevertheless, no significant difference could be detected between patients with ARVD/C with (n = 7) and without (n = 11) PKP2 mutations with regard to the phenotype characteristics and clinical outcomes. Decreased penetrance was prominent in family members. In conclusion, 5 novel PKP2 mutations were identified in a cohort of symptomatic Chinese patients with ARVD/C. N852fsX930 appeared to be a hot-spot mutation in which patients presented with a severe ARVD/C phenotype, and 2/3 had early onset of arrhythmic events. No significant difference was found in phenotype characteristics between patients with ARVD/C with and without PKP2 mutations. The decreased penetrance indicated that an ARVD/C diagnosis cannot solely rely on genotyping results.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19427443 DOI: 10.1016/j.amjcard.2009.01.356
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778